A0A075B6W3_HUMAN Loading...

T cell receptor alpha joining 33 AlphaSync

AlphaFold DB , UniProt , Accession A0A075B6W3, Species HUMAN (Homo sapiens, Human), Gene TRAJ33, Length 19 aa.

						>A0A075B6W3_HUMAN|A0A075B6W3|TRAJ33
XDSNYQLIWGAGTKLIIKP
					

Structure Viewer

Loading PAE data...

(Predicted Aligned Error values between residue pairs)

Download Structure AlphaSync Parameters PDB PAE Table

Site	Residue	pLDDT	pLDDT confidence	pLDDT₁₀	pLDDT10 confidence	SASA	SASA [Å²]	SASA₁₀	SASA10 [Å²]	RSA	RSA unformatted	RSA₁₀	RSA10 unformatted	Surface	Surface10 (not used)	Disorder (not used)	Disorder	Sec. str.	Secondary structure	Isomer	Phi (φ)	Psi (ψ)	Omega (ω)	Chi 1 (χ₁)	Chi 2 (χ₂)	Chi 3 (χ₃)	Chi 4 (χ₄)	Tau (τ)	Contacts (colored by PAE)	Contact details
1	X	79.4	Confident	88.7	Confident	126 Å²	126	127.5 Å²	127.5	100%	1.299	74%	0.739	S	S	*	*				0	121.1	0	0	0	0	0	106.3	S3	G1-S3 PolarHBondContact O-N 2.83Å
2	D	80.9	Confident	89.4	Confident	150 Å²	150	123.8 Å²	123.8	80%	0.802	75%	0.749	S	S	*	*			trans	-68.8	113.4	176.2	-172.7	41.6	0	0	108.1	N4	D2-N4 PolarHBondContact O-N 3.46Å
3	S	81.5	Confident	90	Very high	61 Å²	61	120.8 Å²	120.8	43%	0.427	73%	0.731	S	S	.	*			trans	-85.6	111	-179.6	32.9	0	0	0	109.2	X1 Y5	G1-S3 PolarHBondContact O-N 2.83Å; S3-Y5 VanDerWaalsContact CB-CE2 3.46Å; S3-Y5 VanDerWaalsContact O-CD2 3.31Å; S3-Y5 WeakPolarHBondContact O-CD2 3.31Å; S3-Y5 PolarHBondContact O-N 3.35Å; S3-Y5 WeakPolarHBondContact OG-CE2 3.32Å; S3-Y5 PolarHBondContact OG-OH 3.33Å
4	N	86.2	Confident	90.4	Very high	144 Å²	144	125.9 Å²	125.9	77%	0.77	74%	0.738	S	S	*	*			trans	-69.5	75.7	173.8	-68.9	-39.8	0	0	110.8	D2 Q6	D2-N4 PolarHBondContact O-N 3.46Å; N4-Q6 PolarHBondContact O-N 3.34Å
5	Y	87.5	Confident	90.7	Very high	202 Å²	202	124.2 Å²	124.2	79%	0.792	72%	0.724	S	S	*	*			trans	-70.5	123.5	174.2	-65	-69.8	0	0	110	S3	S3-Y5 VanDerWaalsContact CB-CE2 3.46Å; S3-Y5 VanDerWaalsContact O-CD2 3.31Å; S3-Y5 WeakPolarHBondContact O-CD2 3.31Å; S3-Y5 PolarHBondContact O-N 3.35Å; S3-Y5 WeakPolarHBondContact OG-CE2 3.32Å; S3-Y5 PolarHBondContact OG-OH 3.33Å
6	Q	89.5	Confident	91	Very high	164 Å²	164	125.3 Å²	125.3	77%	0.766	72%	0.724	S	S	*	*			trans	-90.7	135.2	174.5	-64.1	-178.8	-63.7	0	109.6	N4 I8	N4-Q6 PolarHBondContact O-N 3.34Å; Q6-I8 HydrophobicContact CB-CD1 4.45Å; Q6-I8 HydrophobicContact CB-CG1 4.12Å; Q6-I8 PolarHBondContact O-N 3.1Å
7	L	91.9	Very high	91.2	Very high	131 Å²	131	126.1 Å²	126.1	69%	0.686	72%	0.724	S	S	*	*			trans	-79.2	107.8	168.5	-176.2	59.5	0	0	108.3	W9	L7-W9 HydrophobicContact CD2-CH2 3.85Å; L7-W9 HydrophobicContact CD2-CZ2 3.3Å; L7-W9 HydrophobicContact CG-CH2 4.04Å; L7-W9 HydrophobicContact CG-CZ2 3.62Å
8	I	93.6	Very high	91.4	Very high	133 Å²	133	128.8 Å²	128.8	68%	0.682	73%	0.726	S	S	*	*			trans	-110.4	127.9	-178.2	-58.8	172.2	0	0	108.7	Q6	Q6-I8 HydrophobicContact CB-CD1 4.45Å; Q6-I8 HydrophobicContact CB-CG1 4.12Å; Q6-I8 PolarHBondContact O-N 3.1Å
9	W	93.8	Very high	91.5	Very high	134 Å²	134	132.6 Å²	132.6	51%	0.508	76%	0.756	S	S	.	*	P	Polyproline II helix	trans	-99.5	127.3	170.7	-57.7	-82.2	0	0	109.9	L7 T13 L15	L7-W9 HydrophobicContact CD2-CH2 3.85Å; L7-W9 HydrophobicContact CD2-CZ2 3.3Å; L7-W9 HydrophobicContact CG-CH2 4.04Å; L7-W9 HydrophobicContact CG-CZ2 3.62Å; W9-T13 HydrophobicContact CB-CG2 4.21Å; W9-T13 HydrophobicContact CG-CG2 4.42Å; W9-L15 HydrophobicContact CH2-CD2 4.08Å; W9-L15 HydrophobicContact CZ2-CD1 4.18Å; W9-L15 HydrophobicContact CZ2-CD2 3.67Å
10	G	95.3	Very high	91.5	Very high	45 Å²	45	132.6 Å²	132.6	46%	0.464	76%	0.756	S	S	.	*	P	Polyproline II helix	trans	-80.4	171.4	179.6	0	0	0	0	113.3	G12 T13	G10-G12 PolarHBondContact O-N 3.28Å; G10-T13 VanDerWaalsContact O-CB 3.32Å; G10-T13 WeakPolarHBondContact O-CB 2.93Å; G10-T13 PolarHBondContact O-N 3.28Å; G10-T13 VanDerWaalsContact O-N 3.1Å; G10-T13 PolarHBondContact O-OG1 3.41Å
11	A	96.3	Very high	91.5	Very high	113 Å²	113	132.6 Å²	132.6	93%	0.934	76%	0.756	S	S	*	*	T	Hydrogen-bonded Turn	trans	-53.5	135	175.1	0	0	0	0	111.5	T13	A11-T13 VanDerWaalsContact C-N 3.26Å; A11-T13 PolarHBondContact O-N 3.31Å
12	G	97.2	Very high	92.2	Very high	83 Å²	83	133 Å²	133	86%	0.856	73%	0.726	S	S	*	*	T	Hydrogen-bonded Turn	trans	79.7	-6.2	-179	0	0	0	0	115.6	G10	G10-G12 PolarHBondContact O-N 3.28Å
13	T	97.1	Very high	92.8	Very high	85 Å²	85	132 Å²	132	52%	0.521	72%	0.722	S	S	.	*			trans	-76.8	128.6	175.9	-59.6	0	0	0	110.8	W9 G10 A11	W9-T13 HydrophobicContact CB-CG2 4.21Å; W9-T13 HydrophobicContact CG-CG2 4.42Å; G10-T13 VanDerWaalsContact O-CB 3.32Å; G10-T13 WeakPolarHBondContact O-CB 2.93Å; G10-T13 PolarHBondContact O-N 3.28Å; G10-T13 VanDerWaalsContact O-N 3.1Å; G10-T13 PolarHBondContact O-OG1 3.41Å; A11-T13 VanDerWaalsContact C-N 3.26Å; A11-T13 PolarHBondContact O-N 3.31Å
14	K	95.4	Very high	93.5	Very high	191 Å²	191	136.4 Å²	136.4	83%	0.83	74%	0.74	S	S	*	*			trans	-104.2	114.1	175.5	-63.6	-176.7	-178.2	-176.4	110.1
15	L	94.2	Very high	94	Very high	101 Å²	101	135.9 Å²	135.9	53%	0.529	74%	0.738	S	S	.	*			trans	-83.8	124.4	171.6	-177.1	65.2	0	0	109.4	W9 I17	W9-L15 HydrophobicContact CH2-CD2 4.08Å; W9-L15 HydrophobicContact CZ2-CD1 4.18Å; W9-L15 HydrophobicContact CZ2-CD2 3.67Å; L15-I17 HydrophobicContact CD2-CD1 4.36Å; L15-I17 HydrophobicContact CD2-CG1 4.4Å; L15-I17 HydrophobicContact CG-CG1 4.29Å
16	I	95.6	Very high	94.5	Very high	141 Å²	141	131.2 Å²	131.2	72%	0.723	74%	0.735	S	S	*	*			trans	-111	117.8	176.9	-56.4	172.6	0	0	107.7
17	I	95.1	Very high	94.9	Very high	140 Å²	140	128.7 Å²	128.7	72%	0.718	73%	0.732	S	S	*	*			trans	-102.2	126	173	-58.2	-164.3	0	0	108.1	L15	L15-I17 HydrophobicContact CD2-CD1 4.36Å; L15-I17 HydrophobicContact CD2-CG1 4.4Å; L15-I17 HydrophobicContact CG-CG1 4.29Å
18	K	94.2	Very high	95.1	Very high	175 Å²	175	128.5 Å²	128.5	76%	0.761	74%	0.736	S	S	*	*			trans	-96.4	137	169	-63.7	178.1	-176.8	174.8	107.5
19	P	93.8	Very high	95.3	Very high	201 Å²	201	128.1 Å²	128.1	100%	1.305	74%	0.741	S	S	*	*			trans	-60	0	172	29.3	-34.9	0	0	111.2

Retrieved 19 of 19 residues in 7.8 ms (Link to these results)

U.S. Privacy Notice - Disclaimer / Registrations / Copyright Statement - Linking Policy - Notice of Privacy Practices (HIPAA) - Notice of Non‑Discrimination
© Copyright 2026 St. Jude Children's Research Hospital, a not-for-profit, section 501(c)(3).